Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/39770
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMEEKERS, Evelyne-
dc.contributor.authorMULLENS, Wilfried-
dc.date.accessioned2023-03-21T09:45:30Z-
dc.date.available2023-03-21T09:45:30Z-
dc.date.issued2023-
dc.date.submitted2023-03-16T16:49:00Z-
dc.identifier.citationCurrent heart failure reports, 20 (1) , p. 88 -100-
dc.identifier.urihttp://hdl.handle.net/1942/39770-
dc.description.abstractPurpose of Review Heart failure is characterized by episodes of congestion with need for hospitalization. The current metrics lack the accuracy to predict and prevent episodes of congestion and to guide diuretic titration to reach euvolemia in case of decompensation. This article aims to provide answers to the role of urinary sodium measurements in acute and chronic heart failure. Recent Findings In acute heart failure, urinary sodium concentrations at the moment of admission and after diuretic administration are correlated with short- and long-term outcome. As this is a reflection of the degree of sodium retention, it can be used as a guide in the diuretic titration. In chronic heart failure, it might be used to predict and consequently prevent episodes of decompensation. Summary Urinary sodium measurements hold great promises to be a novel diagnostic and therapeutic parameter in patients with acute and chronic heart failure. However, more research is needed.-
dc.language.isoen-
dc.publisherSPRINGERNATURE-
dc.rightsThe Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2023-
dc.subject.otherHeart failure-
dc.subject.otherCardiorenal interactions-
dc.subject.otherNatriuresis-
dc.subject.otherUrinary sodium-
dc.titleSpot Urinary Sodium Measurements: the Future Direction of the Treatment and Follow-up of Patients with Heart Failure-
dc.typeJournal Contribution-
dc.identifier.epage100-
dc.identifier.issue1-
dc.identifier.spage88-
dc.identifier.volume20-
local.format.pages13-
local.bibliographicCitation.jcatA1-
dc.description.notesMeekers, E (corresponding author), Hasselt Univ, Univ Laan 1, B-3500 Hasselt, Belgium.; Meekers, E (corresponding author), Ziekenhuis Oost Limburg, Schiepse Bos 6, B-3600 Genk, Belgium.-
dc.description.notesevelyne.meekers@zol.be; wilfried.mullens@zol.be-
local.publisher.placeCAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND-
local.type.refereedRefereed-
local.type.specifiedArticle-
dc.identifier.doi10.1007/s11897-023-00591-4-
dc.identifier.pmid36807114-
dc.identifier.isi000936353300001-
dc.contributor.orcidMeekers, Evelyne/0000-0002-0204-0132-
local.provider.typewosris-
local.description.affiliation[Meekers, Evelyne; Mullens, Wilfried] Hasselt Univ, Univ Laan 1, B-3500 Hasselt, Belgium.-
local.description.affiliation[Meekers, Evelyne; Mullens, Wilfried] Ziekenhuis Oost Limburg, Schiepse Bos 6, B-3600 Genk, Belgium.-
local.uhasselt.internationalno-
item.fullcitationMEEKERS, Evelyne & MULLENS, Wilfried (2023) Spot Urinary Sodium Measurements: the Future Direction of the Treatment and Follow-up of Patients with Heart Failure. In: Current heart failure reports, 20 (1) , p. 88 -100.-
item.fulltextWith Fulltext-
item.contributorMEEKERS, Evelyne-
item.contributorMULLENS, Wilfried-
item.accessRightsOpen Access-
crisitem.journal.issn1546-9530-
crisitem.journal.eissn1546-9549-
Appears in Collections:Research publications
Show simple item record

WEB OF SCIENCETM
Citations

3
checked on Sep 27, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.